This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
World Health Organization Reports; 2020. Available from: www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-operations.World Health Organization Reports2020Available from: www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-operations.Search in Google Scholar
Zunyou W, Jennifer M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323: 1239–1242.ZunyouWJenniferMCharacteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China summary of a report of 72 314 cases from the Chinese center for disease control and preventionJAMA20203231239124210.1001/jama.2020.2648Search in Google Scholar
Nishiura H, Kobayashi T, Miyama T, Suzuki A., Jung S-M, Hayashi K, et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). International Journal of Infectious Diseases, 2020;94: 154–155.NishiuraHKobayashiTMiyamaTSuzukiA.JungS-MHayashiKEstimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)International Journal of Infectious Diseases20209415415510.1016/j.ijid.2020.03.020Search in Google Scholar
Dawei W, Bo H, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel corona-virus–infected pneumonia in Wuhan, China. JAMA 2020;323: 1061–1069.DaweiWBoHHuCZhuFLiuXZhangJClinical characteristics of 138 hospitalized patients with 2019 novel corona-virus–infected pneumonia in Wuhan, ChinaJAMA20203231061106910.1001/jama.2020.1585Search in Google Scholar
Chaolin H, Yeming W, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506.ChaolinHYemingWLiXRenLZhaoJHuYClinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaLancet202039549750610.1016/S0140-6736(20)30183-5Search in Google Scholar
Wei-Jie G, Wen-Hua L, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. European Respiratory Journal 2020;55: 2000547.Wei-JieGWen-HuaLZhaoYLiangHRChenZSLiYMComorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysisEuropean Respiratory Journal202055200054710.1183/13993003.00547-2020Search in Google Scholar
Haibo Q, Zhaohui T, Ma P, Hu M, Peng Z, Wu W, et al. Intensive care during the coronavirus epidemic. Intensive Care Medicine 2020;46: 576–578.HaiboQZhaohuiTMaPHuMPengZWuWIntensive care during the coronavirus epidemicIntensive Care Medicine20204657657810.1007/s00134-020-05966-ySearch in Google Scholar
Leung JM, Yang CX, Tam Y, Shaipanich T, Hackett T-L, et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. European Respiratory Journal. 2020; in press Available from: doi.org/10.1183/13993003.00688-2020.LeungJMYangCXTamYShaipanichTHackettT-LACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19European Respiratory Journal2020in press Available from: doi.org/10.1183/13993003.00688-2020.10.1183/13993003.00688-2020Search in Google Scholar
Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging 2020;12: 6049–6057.WangBLiRLuZHuangYDoes comorbidity increase the risk of patients with COVID-19: evidence from meta-analysisAging2020126049605710.18632/aging.103000Search in Google Scholar
Singh AK, Gillies CL, et al. The prevalence of comorbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis. Diabetes Obes Metab. 2020;22:1915–1924.SinghAKGilliesCLThe prevalence of comorbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysisDiabetes Obes Metab2020221915192410.2139/ssrn.3576854Search in Google Scholar
Fei Z, Ting Y, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395: 1054–1062.FeiZTingYDuRFanGLiuYLiuZClinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyLancet20203951054106210.1016/S0140-6736(20)30566-3Search in Google Scholar
Zhang, J-J, Dong X, Cao Y-Y, Yuan YD, Yang Y-B, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARSCoV-2 in Wuhan, China. Allergy. 2020;75: 1–12. Available from: doi:
10.1111/all.14238.ZhangJ-JDongXCaoY-YYuanYDYangY-BYanYQClinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, ChinaAllergy202075112Available from:10.1111/all.14238Open DOISearch in Google Scholar
Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Archives of Academic Emergency Medicine 2020;8(1): e35.EmamiAJavanmardiFPirbonyehNAkbariAPrevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysisArchives of Academic Emergency Medicine202081e3510.1371/journal.pone.0241265Search in Google Scholar
Nanshan C, Min Z, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395: 507–513.NanshanCMinZDongXQuJGongFHanYEpidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-7Search in Google Scholar
Restrepo MI, Mortensen EM, Pugh JA, Anzueto. COPD is associated with increased mortality in patients with community acquired pneumonia. European Respiratory Journal. 2006;28: 346–335.RestrepoMIMortensenEMPughJAAnzuetoCOPD is associated with increased mortality in patients with community acquired pneumoniaEuropean Respiratory Journal20062834633510.1183/09031936.06.0013190516611653Search in Google Scholar
Soriano J, Visick G, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005;128: 2099–2107.SorianoJVisickGMuellerovaHPayvandiNHansellALPatterns of comorbidities in newly diagnosed COPD and asthma in primary careChest20051282099210710.1378/chest.128.4.209916236861Search in Google Scholar
Restrepo MI, Sibila O, Anzueto A. Pneumonia in patients with chronic obstructive pulmonary disease. Tuberculosis and Respiratory Diseases. 2018;81: 187–197.RestrepoMISibilaOAnzuetoAPneumonia in patients with chronic obstructive pulmonary diseaseTuberculosis and Respiratory Diseases20188118719710.4046/trd.2018.0030603066229962118Search in Google Scholar
Divo MJ, Casanova C, Marin JM, Pinto-Plata VM, de Torres JP, Zulueta JJ, et al. COPD comorbidities network. European Respiratory Journal. 2015;46: 640–650.DivoMJCasanovaCMarinJMPinto-PlataVMde TorresJPZuluetaJJCOPD comorbidities networkEuropean Respiratory Journal20154664065010.1183/09031936.0017161426160874Search in Google Scholar
Vanfleteren LEGW, Spruit MA, Groenen M, Gaffron S, van Empel VPM, Bruijnzeel PLB, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 2013;187: 729–735.VanfleterenLEGWSpruitMAGroenenMGaffronSvan EmpelVPMBruijnzeelPLBClusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary diseaseAmerican Journal of Respiratory and Critical Care Medicine201318772973510.1164/rccm.201209-1665OC23392440Search in Google Scholar
Raherison C, Quaalaya EH, Bernady A, Casteigt J, Nocent-Eijnani C, Falque L, et al. Comorbidities and COPD severity in a clinic-based cohort. BMC Pulmonary Medicine. 2018;18: 117.RaherisonCQuaalayaEHBernadyACasteigtJNocent-EijnaniCFalqueLComorbidities and COPD severity in a clinic-based cohortBMC Pulmonary Medicine20181811710.1186/s12890-018-0684-7604883430012144Search in Google Scholar
Hadi ARH, Zubaid M, Mahmeed WA, El-Menyar AA, Ridha M, Alsheikh AA, et al. Prevalence and prognosis of chronic obstructive pulmonary disease among 8167 middle eastern patients with acute coronary syndrome. Clinical Cardiology 2010;33: 228–235.HadiARHZubaidMMahmeedWAEl-MenyarAARidhaMAlsheikhAAPrevalence and prognosis of chronic obstructive pulmonary disease among 8167 middle eastern patients with acute coronary syndromeClinical Cardiology20103322823510.1002/clc.20751665301020394044Search in Google Scholar
Tuleta I, Farrag T, Busse L, Pizarro C, Schaefer C, Pingel S, et al. High prevalence of COPD in atherosclerosis patients. International Journal of Chronic Obstructive Pulmonary Disease. 2017;12: 3047–3053.TuletaIFarragTBusseLPizarroCSchaeferCPingelSHigh prevalence of COPD in atherosclerosis patientsInternational Journal of Chronic Obstructive Pulmonary Disease2017123047305310.2147/COPD.S141988565512229089753Search in Google Scholar
Davis WA, Knuiman M, Kendall P, Grange V, Davis TMV. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes the fremantle diabetes study. Diabetes Care. 2004;27: 752–757.DavisWAKnuimanMKendallPGrangeVDavisTMVGlycemic exposure is associated with reduced pulmonary function in type 2 diabetes the fremantle diabetes studyDiabetes Care20042775275710.2337/diacare.27.3.75214988297Search in Google Scholar
Kaye L, Theye B, et al. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. The Journal of Allergy and Clinical Immunology: In Practice. 2020;20: 230412-8.KayeLTheyeBChanges in medication adherence among patients with asthma and COPD during the COVID-19 pandemicThe Journal of Allergy and Clinical Immunology: In Practice202020230412-810.1016/j.jaip.2020.04.053719403632371047Search in Google Scholar
Celli B, Fabbri LM. Urgent need of a management plan for survivors of COVID-19. European Respiratory Journal. 2020;2000764.CelliBFabbriLMUrgent need of a management plan for survivors of COVID-19European Respiratory Journal2020200076410.1183/13993003.00764-2020709847932217657Search in Google Scholar
Singh D., Agusti A., Anzueto A. et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. European Respiratory Journal 2019;53: 1900164.SinghD.AgustiA.AnzuetoA.Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019European Respiratory Journal201953190016410.1183/13993003.00164-201930846476Search in Google Scholar
